WMSA
VYGR icon

Weiss Multi-Strategy Advisers’s Voyager Therapeutics VYGR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,935
Closed -$214K – 688
2020
Q2 		$214K Buy
16,935
+582
+4% +$6.77K 0.01% 513
2020
Q1 		$150K Buy
16,353
+353
+2% +$4.05K 0.01% 395
2019
Q4 		$223K Buy
16,000
+6,000
+60% +$87.2K ﹤0.01% 570
2019
Q3 		$172K Hold
10,000
– – ﹤0.01% 550
2019
Q2 		$272K Buy
+10,000
New +$229K 0.01% 458
2019
Q1 		– Sell
-11,000
Closed -$103K – 623
2018
Q4 		$103K Buy
11,000
+1,000
+10% +$12.8K ﹤0.01% 426
2018
Q3 		$189K Buy
+10,000
New +$192K 0.01% 490

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's VYGR Position: Q3 2020 in Review

Weiss Multi-Strategy Advisers sold out of Voyager Therapeutics (VYGR) in Q3 2020, closing a stake of 16,935 shares — an estimated $214K sold.

Weiss Multi-Strategy Advisers first reported a position in VYGR in Q3 2018 and held it in 7 quarters. The position peaked at $272K in Q2 2019. 110 funds tracked by Wall St. Rank hold VYGR as of Q3 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Voyager Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 16,935 Voyager Therapeutics shares in Q3 2020, an estimated $214K.
  • Weiss Multi-Strategy Advisers first reported a position in Voyager Therapeutics in Q3 2018 and held it in 7 quarters.
  • Weiss Multi-Strategy Advisers's Voyager Therapeutics position peaked at $272K in Q2 2019.
  • 110 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2020, filed 16 Nov 2020.